Mylène A. Carrascal

1.1k total citations
29 papers, 756 citations indexed

About

Mylène A. Carrascal is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Mylène A. Carrascal has authored 29 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 15 papers in Immunology and 5 papers in Oncology. Recurrent topics in Mylène A. Carrascal's work include Glycosylation and Glycoproteins Research (13 papers), Immunotherapy and Immune Responses (11 papers) and Cancer Research and Treatments (4 papers). Mylène A. Carrascal is often cited by papers focused on Glycosylation and Glycoproteins Research (13 papers), Immunotherapy and Immune Responses (11 papers) and Cancer Research and Treatments (4 papers). Mylène A. Carrascal collaborates with scholars based in Portugal, Italy and United States. Mylène A. Carrascal's co-authors include Paula A. Videira, Maria Teresa Cruz, Bruno Miguel Neves, Célia Gomes, Amílcar Falcão, Fabio Dall’Olio, Paulo F. Severino, Lúcio Lara Santos, Mariana Silva and José Alexandre Ferreira and has published in prestigious journals such as International Journal of Molecular Sciences, Small and Cellular and Molecular Life Sciences.

In The Last Decade

Mylène A. Carrascal

28 papers receiving 745 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mylène A. Carrascal Portugal 15 446 351 179 76 72 29 756
Sonja M. Walzer Austria 15 468 1.0× 270 0.8× 103 0.6× 35 0.5× 49 0.7× 24 798
Pirkko Mattila Finland 17 382 0.9× 261 0.7× 59 0.3× 43 0.6× 56 0.8× 37 854
Mikiko Fukui Japan 10 338 0.8× 384 1.1× 272 1.5× 103 1.4× 69 1.0× 13 772
David Calianese United States 13 419 0.9× 636 1.8× 154 0.9× 47 0.6× 55 0.8× 20 1.0k
Kyoko Kojima United States 18 523 1.2× 152 0.4× 162 0.9× 24 0.3× 71 1.0× 30 860
Xing Gu China 17 621 1.4× 187 0.5× 174 1.0× 48 0.6× 72 1.0× 60 1.0k
Paul M. Grandgenett United States 21 594 1.3× 207 0.6× 341 1.9× 58 0.8× 71 1.0× 35 1.1k
Roopa Srinivasan United States 11 384 0.9× 771 2.2× 399 2.2× 89 1.2× 33 0.5× 17 1.0k
Rebecca J. Boohaker United States 15 612 1.4× 148 0.4× 198 1.1× 82 1.1× 24 0.3× 34 897
Margaret S. Dordal United States 10 432 1.0× 215 0.6× 129 0.7× 92 1.2× 42 0.6× 12 822

Countries citing papers authored by Mylène A. Carrascal

Since Specialization
Citations

This map shows the geographic impact of Mylène A. Carrascal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mylène A. Carrascal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mylène A. Carrascal more than expected).

Fields of papers citing papers by Mylène A. Carrascal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mylène A. Carrascal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mylène A. Carrascal. The network helps show where Mylène A. Carrascal may publish in the future.

Co-authorship network of co-authors of Mylène A. Carrascal

This figure shows the co-authorship network connecting the top 25 collaborators of Mylène A. Carrascal. A scholar is included among the top collaborators of Mylène A. Carrascal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mylène A. Carrascal. Mylène A. Carrascal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Falcão, Amílcar, et al.. (2025). Dendritic cells in triple-negative breast cancer: From pathophysiology to therapeutic applications. Cancer Treatment Reviews. 133. 102884–102884. 4 indexed citations
2.
Cunha, Joana, Carla Vitorino, Célia Gomes, et al.. (2024). The potential of exosomes as a new therapeutic strategy for glioblastoma. European Journal of Pharmaceutics and Biopharmaceutics. 203. 114460–114460. 14 indexed citations
3.
Correia‐da‐Silva, Marta, Mylène A. Carrascal, Madalena Pinto, et al.. (2024). Persulfated Ascorbic Acid Glycoside as a Safe and Stable Derivative of Ascorbic Acid for Skin Care Application. Molecules. 29(19). 4604–4604.
4.
Pascoal, Carlota, Mylène A. Carrascal, Ana Rita Grosso, et al.. (2023). Sialyl LewisX/A and Cytokeratin Crosstalk in Triple Negative Breast Cancer. Cancers. 15(3). 731–731. 5 indexed citations
5.
Carrascal, Mylène A., Cátia Sousa, Luísa Cortes, et al.. (2023). CuMV VLPs Containing the RBM from SARS-CoV-2 Spike Protein Drive Dendritic Cell Activation and Th1 Polarization. Pharmaceutics. 15(3). 825–825. 5 indexed citations
6.
Pereira, Ana Catarina, Rosa Resende, Susana Cardoso, et al.. (2022). ER-mitochondria communication is involved in NLRP3 inflammasome activation under stress conditions in the innate immune system. Cellular and Molecular Life Sciences. 79(4). 213–213. 43 indexed citations
7.
Catarino, Marcelo D., Iva Fernandes, Hélder Oliveira, et al.. (2021). Antitumor Activity of Fucus vesiculosus-Derived Phlorotannins through Activation of Apoptotic Signals in Gastric and Colorectal Tumor Cell Lines. International Journal of Molecular Sciences. 22(14). 7604–7604. 27 indexed citations
8.
Duarte, Iola F., Daniel Ferreira, Célia Gomes, et al.. (2021). In-Depth Analysis of the Impact of Different Serum-Free Media on the Production of Clinical Grade Dendritic Cells for Cancer Immunotherapy. Frontiers in Immunology. 11. 593363–593363. 13 indexed citations
9.
Carrascal, Mylène A., et al.. (2021). Exosomes as new therapeutic vectors for pancreatic cancer treatment. European Journal of Pharmaceutics and Biopharmaceutics. 161. 4–14. 14 indexed citations
10.
Ferreira, Isabel, et al.. (2020). Allergic contact dermatitis: From pathophysiology to development of new preventive strategies. Pharmacological Research. 162. 105282–105282. 37 indexed citations
11.
Carrascal, Mylène A., Daniel Ferreira, Célia Gomes, et al.. (2020). Dendritic Cell Vaccines for Cancer Immunotherapy: The Role of Human Conventional Type 1 Dendritic Cells. Pharmaceutics. 12(2). 158–158. 80 indexed citations
12.
Silva, Ana, Mylène A. Carrascal, Bruno Miguel Neves, et al.. (2020). Calcium Modulation, Anti-Oxidant and Anti-Inflammatory Effect of Skin Allergens Targeting the Nrf2 Signaling Pathway in Alzheimer’s Disease Cellular Models. International Journal of Molecular Sciences. 21(20). 7791–7791. 10 indexed citations
13.
Carrascal, Mylène A., Daniel Ferreira, Célia Gomes, et al.. (2020). Pharmacological combination of nivolumab with dendritic cell vaccines in cancer immunotherapy: An overview. Pharmacological Research. 164. 105309–105309. 10 indexed citations
14.
Carrascal, Mylène A., et al.. (2019). Biomaterial-based platforms for in situ dendritic cell programming and their use in antitumor immunotherapy. Journal for ImmunoTherapy of Cancer. 7(1). 238–238. 39 indexed citations
15.
Carrascal, Mylène A., José Alexandre Ferreira, Rita Azevedo, et al.. (2018). A functional glycoproteomics approach identifies CD13 as a novel E-selectin ligand in breast cancer. Biochimica et Biophysica Acta (BBA) - General Subjects. 1862(9). 2069–2080. 25 indexed citations
16.
Severino, Paulo F., Mariana Silva, Mylène A. Carrascal, et al.. (2018). Oxidative damage and response to Bacillus Calmette-Guérin in bladder cancer cells expressing sialyltransferase ST3GAL1. BMC Cancer. 18(1). 198–198. 14 indexed citations
17.
Araújo, J.E., Hugo López-Fernández, Mário Diniz, et al.. (2017). Dithiothreitol-based protein equalization technology to unravel biomarkers for bladder cancer. Talanta. 180. 36–46. 10 indexed citations
18.
Carrascal, Mylène A., José S. Ramalho, Carlota Pascoal, et al.. (2017). Inhibition of fucosylation in human invasive ductal carcinoma reduces E‐selectin ligand expression, cell proliferation, and ERK1/2 and p38 MAPK activation. Molecular Oncology. 12(5). 579–593. 53 indexed citations
19.
Carrascal, Mylène A., Paulo F. Severino, M. Guadalupe Cabral, et al.. (2014). Sialyl Tn‐expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells. Molecular Oncology. 8(3). 753–765. 89 indexed citations
20.
Videira, Paula A., M. Guadalupe Cabral, Catarina Martins, et al.. (2011). Effects of Bevacizumab on Autocrine VEGF Stimulation in Bladder Cancer Cell Lines. Urologia Internationalis. 86(1). 95–101. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026